PTK2 and uveal melanoma: Interestingly, extended treatment of uveal melanoma cell lines with a chemically different small-molecule FAKi (Verastem, VS-4718) also resulted in higher levels of basal ERK activity (38), suggesting that our observed responses with murine ovarian and HGSOC cells may be a more general tumor cell response to FAK inhibition.